GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:14732731

From GONUTS
Jump to: navigation, search
Citation

Zeng, C, Wang, D, Asico, LD, Welch, WJ, Wilcox, CS, Hopfer, U, Eisner, GM, Felder, RA and Jose, PA (2004) Aberrant D1 and D3 dopamine receptor transregulation in hypertension. Hypertension 43:654-60

Abstract

Dopamine plays a role in the regulation of blood pressure by inhibition of sodium transport in renal proximal tubules (RPTs) and relaxation of vascular smooth muscles. Because dopamine receptors can regulate and interact with each other, we studied the interaction of D(1) and D(3) receptors in immortalized RPT cells and mesenteric arteries from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs), and in human coronary artery smooth muscle cells (CASMCs). In WKY rats, the D(1)-like agonist, fenoldopam, increased D(3) receptor protein in a time-dependent and concentration-dependent manner (EC(50)=4.5x10(-9) M, t(1/2)=15.8 hours). In SHRs, fenoldopam (10(-5) M) actually decreased the expression of D(3) receptors. D(1) and D(3) receptor co-immunoprecipitation was increased by fenoldopam (10(-7) M/24 h) in WKY rats but not in SHRs. The effects of fenoldopam in CASMCs were similar as those in WKY RPT cells (ie, fenoldopam increased D(1) and D(3) receptor proteins). Both D(3) (PD128907, Emax=80%+/-6%, pED(50)=5+/-0.1) and D(1)-like receptor (fenoldopam, Emax=81%+/-8%, pED(50)=5+/-0.2, n=12) agonists relaxed mesenteric arterial rings. Co-stimulation of D(1) and D(3) receptors led to additive vasorelaxation in WKY rats, but not in SHRs. D(1) and D(3) receptors interact differently in WKY and SHRs. Altered interactions between D(1) and D(3) receptors may play a role in the pathogenesis of genetic hypertension, including human hypertension, because these receptors also interact in human vascular smooth muscle cells.

Links

PubMed Online version:10.1161/01.HYP.0000114601.30306.bf

Keywords

Animals; Cell Line; Coronary Vessels/cytology; Dopamine Agonists/pharmacology; Fenoldopam/pharmacology; Humans; Hypertension/metabolism; Hypertension/physiopathology; Kidney Tubules, Proximal/drug effects; Kidney Tubules, Proximal/metabolism; Male; Mesenteric Arteries/physiopathology; Muscle, Smooth, Vascular/cytology; Muscle, Smooth, Vascular/metabolism; Precipitin Tests; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine D1/agonists; Receptors, Dopamine D1/metabolism; Receptors, Dopamine D2/agonists; Receptors, Dopamine D2/metabolism; Receptors, Dopamine D3; Vasodilation

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:DRD3

enables

GO:0031748: D1 dopamine receptor binding

ECO:0000353: physical interaction evidence used in manual assertion

RGD:2518

F

Seeded From UniProt

complete

RAT:DRD1

enables

GO:0031750: D3 dopamine receptor binding

ECO:0000353: physical interaction evidence used in manual assertion

RGD:2521

F

Seeded From UniProt

complete

Notes

See also

References

See Help:References for how to manage references in GONUTS.